Hualan Pharmaceutical Trade Co., Ltd.
Hualan Pharmaceutical Trade Co., Ltd. (hereinafter the “Company”), being established on February 28, 2005, is a holding subsidiary of Hualan Biological Engineering Inc., specializing in distribution of biological products and vaccines, including Human Albumin; Human Immunoglobulin; Tetanus Human Immunoglobulin; Hepatitis B Human Immunoglobulin; Human Rabies Immunoglobulin; IVIG; Factor VIII, Lyophilized; Prothrombin Complex, Lyophilized; Influenza Vaccine (Split Virion), Inactivated; Meningococcal Polysaccharide Vaccine Group ACYW135; Recombinant Hepatitis B Vaccine (Hansenula polymorpha) etc.
The Company realizes an increased distribution scale annually by taking advantage of marketing resources of Hualan Biological Engineering Inc. By 2009, the distribution scale has reached 450 million CNY. From drug purchase and acceptance inspection to drug transportation by cold chain, each step is strictly operated as procedures. The company controls the drugs quality strictly during the circulation, adhering to “To ensure the reputation by quality and safety”. The company owns independent cold-chain transportation team, and implements electronic monitoring to the whole journey, from purchase to storage; GPS gets exactly the real-time position and the temperature of the drugs; and the electronic monitoring code is able to track the whole purchase-sell process of every drug; all of these efficiently ensure the quality and safety of biological products and vaccines during circulation.
The Company also has a professional marketing team with more than 200 persons, what is more, and 90% of them has college degree or above related to medicine and pharmacy. There are offices in various provinces, cities and autonomous regions, so after-sale service network covers almost the whole country.
In the future, we will always stick to the corporate philosophy of “All for Human Health” and contribute more to human health.
Hualan Biological Bacterin Co., Ltd.
Located in Xinxiang City of Henan Province, Hualan Biological Bacterin Co., Ltd., is a subsidiary company of Hualan Biological Engineering Inc. It covers a field of 180, 000 ㎡, with 55,ooo㎡ building area and over 10,000㎡ classified clean area . The land is divided into the office area, manufacturing area and auxiliary area rationally, which complies with the national GMP and other specifications. In addition, the factory is also designed to meet the WHO GMP specifications. It is one of the largest modern vaccine manufacturing bases in China. The company specializes in the R&D of bacterial vaccines, viral vaccines and genetic engineering vaccines for human use. The manufacturing equipment, QC laboratories, experimental animal center and auxiliary facilities are well designed and equipped with high quality and standard, which enables to maximally meet the demand of vaccine production during the outbreak in a very short period. The company implemented a complete quality management system to ensure the safety and efficacy of each vaccine. The large scale automated cold room has a storage capacity of 100 million vials of vaccines, which combined with many large and mini refrigerated vehicles ensures the timeliness and cold chain requirements for vaccine transportation.
Hualan Biological Bacterin Co., Ltd. is ready to offer the best service and products to the CDCs, and commit itself to build an unbreakable immune Great Wall for the general population.
Hualan Biological Engineering (Chongqing) Co., Ltd.
Hualan Biological Engineering (Chongqing) Co., Ltd. is a wholly-owned subsidiary of Hualan Biological Engineering Inc. in Chongqing Municipality, which is the only plasma product enterprise in Chongqing, as well as the largest enterprise of plasma product in China. The company was approved on August 15, 2007 by the Industrial and Commercial Bureau of Fuling District, and broke ground at Lidu Industrial Park on August 16. 300 million CNY is invested in the first-stage project. The factory is designed to process normal human plasma 1,000 tons per year, covering an area of 58,600 ㎡ and building area 30,000 ㎡. The mainly products are plasma products, including Human Albumin, IVIG, Human Tetanus Immunoglobulin, Human Immunoglobulin, Coagulation Factor VIII, Prothrombin Complex, etc. After full production, it will be the largest, most complete varieties and highest automation degree manufacturer of plasma products in China, or even in Asia, which will greatly ease the situation of serious domestic shortage of plasma products. The company strives to realize the product diversity and expansion of industry chain. The second-stage project will expand to R&D of vaccines and genetic drugs, maximally increasing the added value of products.
Hualan Biological Engineering (Chongqing) Co., Ltd., as key investment enterprise in Chongqing, has invested almost CNY 300 million, possessing the independent development right of source plasma in Chongqing. On March 10, 2009, with the supports of Chongqing government, Fuling District government as well as the unremitting efforts of Hualan staff, the company successfully passed the acceptance inspection, then is granted the drug manufacturing certificate by Chongqing FDA. The pilot production is completed under the supervision of Chongqing FDA, and the products are qualified by NICPBP. As for raw material, seven plasma stations are approved by Chongqing Blood Collecting and Supplying Planning; Wulong, Zhongxian, Kaixian and Tongnan stations are completed; Wuxi station is waiting for inspection, Pengshui station is almost completed; and Ba’nan station is being replaced by site selection.
Hualan Biological Engineering (Suzhou) Co., Ltd.
Hualan Biological Engineering (Suzhou) Co., Ltd. is located in Suzhou National New and Hi-Tech Development Zone with a total investment of USD 15 million. It has great geographical advantage for locating in the economic circle of Yantze River Delta. The company integrates the R&D, production and sales of plasma products, genetic products, protein chips and other biological products, and has a processing capacity of 1,200 tons of plasma every year. It passed the GMP by SFDA in March 2005, creating a new page in the biopharmaceutical industry in Jiangsu Province.